International Journal of Oral Biology

The Korean Academy of Oral Biology (대한구강생물학회)
권호 표지

The effects of sex hormones on the expression of ODF and OPG in human gingival fibroblast and periodontal ligament cell at normal menstruation cycle and menopause.

  • Shin, Ji-Yearn (Dept. of Periodontology, School of Dentistry, Seoul National University) ;
  • Baek, Dong-Heon (Oral Microbiology and Immunology, Dankook University) ;
  • Han, Soo-Boo (Dept. of Periodontology, School of Dentistry, Seoul National University)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Periodontitis is a chronic infectious disease that leads to periodontal destruction, and is one of the major causes of tooth loss in humans. The osteoclast differentiation factor (ODF), which is also known as the receptor activator of the NF-kB ligand (RANKL), is a surface-associated ligand on bone marrow stromal cells and osteoblasts. RANKL activates its cognate receptor, RANK, on osteoclast progenitor cells, which leads to the differentiation of mononucleated precursor cells. Osteoprotegerin (OPG) is a decoy receptor that is released from stromal cells and osteoblasts to inhibit the interaction between RANKL and RANK. Although the precise mechanism of bone loss in periodontitis is unknown, the differentiation and activation of osteoclasts by OPG-ODF-RANK signaling might play the role in periodontal bone destruction. The relationship between the concentration of sex hormones and the expression of ODF and OPG was examined by treating human gingival fibroblasts and periodontal ligament cells with the normal serum concentration of estrogen or progesterone during menstruation or at menopause. The ODF/OPG relative ratio was elevated at the concentration observed during ovulation in human gingival fibroblasts and at the concentration observed between ovulation and menstruation in periodontal ligament cells treated with estrogen. However, the ratio was <1 at all concentrations in both cells treated with progesterone. In the case of menopause simulated by estrogen depletion, the ratio was <1 in human gingival fibroblasts but >1 in periodontal ligament cells.

Keywords

References

  1. Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D. and Galibert, L.: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature. 390:175-179, 1997 https://doi.org/10.1038/36593
  2. Aubin, J.E., Bonnelye, E.: Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos. Int. 11:905-913, 2000 https://doi.org/10.1007/s001980070028
  3. Birkedal-Hansen, H.: Related articles role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal Res. 28:500-510, 1993 https://doi.org/10.1111/j.1600-0765.1993.tb02113.x
  4. Bostrom, L., Linder, L.E. and Bergstrom, J.: Clinical expression of TNF-alpha in smoking-associated periodontal disease. J. Clin. Periodontol. 25:767-773, 1998 https://doi.org/10.1111/j.1600-051X.1998.tb02368.x
  5. Boyce, B.F., Yamashita, T., Yao, Z., Zhang, Q., Li, F. and Xing L. : Roles for NF-KappaB and c-fos in osteoclasts. J. Bone Miner. Metab. 23(suppl):11-15, 2005 https://doi.org/10.1007/BF03026317
  6. Brown, L.J., Oliver, R.C. and Loe, H.: Evaluating periodontal status of US employed adults. J. Am. Dent. Assoc. 121:226- 232, 1990 https://doi.org/10.14219/jada.archive.1990.0252
  7. Clark, W.H. and Loe, H.: Mechanisms of initiation and progression of periodontal disease. Periodontol. 2000. 2:72- 82, 1993
  8. Eklund, S.A. and Burt, B.A.: Risk factors for total tooth loss in the United States; longitudinal analysis of national data. J. Public Health Dent. 54:5-14, 1994 https://doi.org/10.1111/j.1752-7325.1994.tb01173.x
  9. Fukushima, H., Kajiya, H., Takada, K., Okamoto F. and Okabe, K.: Expression and role of RANKL in periodontal ligament cells during physiological non-resorption in human deciduous teeth. Eur. J. Oral Sci. 111:346-352, 2003 https://doi.org/10.1034/j.1600-0722.2003.00051.x
  10. Galbraith, G.M., Hagan, C., Steed, R.B., Sanders, J.J. and Javed, T.: Cytokine production by oral and peripheral blood neutrophils in adult periodontitis. J. Periodontol. 68:832- 838, 1997 https://doi.org/10.1902/jop.1997.68.9.832
  11. Hofbauer, L.C., Kuhne, C.A. and Viereck, V.: The OPG/ RANKL/RANK system in metabolic bone diseases. J. Musculoskelet. Neuronal Interact. 3:268-275, 2004
  12. Hofbauer, L.C. and Schoppet, M.: Clinical implications of the osteoprotegerin/ RANKL/ RANK system for bone and vascular diseases. JAMA 292:490-495, 2004 https://doi.org/10.1001/jama.292.4.490
  13. Klinger, G., Eick, S., Kinger, G., Pfister W., Graser T., Moore, C. and Oettel, M.: Influence of hormonal contraceptives on microbial flora of gingival sulcus. Contraception 57:381- 384, 1998 https://doi.org/10.1016/S0010-7824(98)00044-4
  14. Kong, Y.Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., Wong, T., Campagnuolo, G., Moran, E., Bogoch, E.R., Van, G., Nguyen, L.T., Ohashi, P.S., Lacey, D.L., Fish, E., Boyle, W.J. and Penninger, J.M.: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 401:304-309, 1999 https://doi.org/10.1038/45853
  15. Kwon, B.S., Wang, S., Udagawa, N., Haridas, V., Lee, Z.H., Kim, K.K., Oh, K.O., Greene, J., Li, Y., Su, J., Gentz, R., Aggarwal, B.B. and Ni, J.: TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J. 12:845-854, 1998 https://doi.org/10.1096/fasebj.12.10.845
  16. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y.X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J. and Boyle, W.J.: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176, 1998 https://doi.org/10.1016/S0092-8674(00)81569-X
  17. Liu, D., Xu, J.K., Figliomeni, L., Huang, L., Pavlos, N.J., Rogers, M., Tan, A., Price, P. and Zheng, M.H.: Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 11:17-21, 2003
  18. Lossdorfer, S., Gotz, W. and Jager, A.: Immunohistochemical localization of receptor activator of nuclear factor eB (RANK) and its ligand(RANKL) in human deciduous teeth. Calcif. Tissue Int. 71:45-52, 2002 https://doi.org/10.1007/s00223-001-2086-7
  19. Loza, J.C., Carpio, L.C. and Dziak, R.: Osteoporosis and its relationship to oral bone loss. Curr. Opin. Periodontol. 3:27- 33, 1996
  20. Machtei, E.E., Mahler, D., Sanduri, H. and Peled, M.: The effect of menstrual cycle on periodontal health. J. Periodontol. 75:408-412, 2004 https://doi.org/10.1902/jop.2004.75.3.408
  21. Manolagas, S.C.: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endory. Rev. 21:115-137, 2000 https://doi.org/10.1210/er.21.2.115
  22. Mogi, M., Otogoto, J., Ota, N. and Togari, A.: Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J. Dent. Res. 83:166-169, 2004 https://doi.org/10.1177/154405910408300216
  23. Nakagawa, S., Fujii, H., Machida, Y. and Okuda, K.: A longitudinal study of gingivitis from prepuberty to puberty. Correlation between the occurrence of Prevotella intermedia and sex hormones. J. Clin. Periodontol. 21:658-665, 1994 https://doi.org/10.1111/j.1600-051X.1994.tb00783.x
  24. Oshiro, T., Shiotani, A., Shibasaki, T and Sasaki T.: Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Anat. Rec. 266:218-225, 2002 https://doi.org/10.1002/ar.10061
  25. Raber-Durlacher, J.E., van Steenbergen, T.J., Van der Velden, U., de Graaff, J. and Abraham-Inpijn, L.: Experimental gingivitis during pregnancy and post-partum: Clinical, endocrinological, and microbiological aspects. J. Clin. Periodontol . 21:549-558, 1994 https://doi.org/10.1111/j.1600-051X.1994.tb01172.x
  26. Rateitschak, K.H.: Tooth mobility changes during pregnancy. J. Peridont. Res. 2:199-206, 1967 https://doi.org/10.1111/j.1600-0765.1967.tb01890.x
  27. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H.L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R. and Boyle, W.J.: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319, 1997 https://doi.org/10.1016/S0092-8674(00)80209-3
  28. Styrt, B. and Sugarman, B.: Estrogens and infection. Rev. Infect. Dis. 13:1139-1150, 1991 https://doi.org/10.1093/clinids/13.6.1139
  29. Tan, K.B., Harrop, J., Reddy, M., Young, P., Terrett, J., Emery, J., Moore, G. and Truneh, A.: Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and nonhematopoietic cells. Gene 204:35-46, 1997 https://doi.org/10.1016/S0378-1119(97)00509-X
  30. Tani-Ishii, N., Tsunoda, A., Teranaka, T. and Umemoto, T.: Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. J. Dent. Res. 78:1617-1623, 1999 https://doi.org/10.1177/00220345990780100601
  31. Tezal, M., Wactawski-Wende, J., Grossi, S.G., Ho, A.W., Dunford, R. and Genco, R.J.: The relationship between bone mineral density and periodontitis in postmenopausal women. J. Periodontol. 71:1492-1498, 2000 https://doi.org/10.1902/jop.2000.71.9.1492
  32. Tsuda, E., Goto, M., Mochizuki, S., Yano, K., Kobayashi, F., Morinaga, T. and Higashio, K.: Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234:137-142, 1997 https://doi.org/10.1006/bbrc.1997.6603
  33. Vittek, J., Hernendez, M.R., Wennk, E.J., Rappaport, S.C. and Southren, A.L.: Specific estrogen receptors in human gingiva. J. Clin. Endocrinol. Metab. 54:608-612, 1982a https://doi.org/10.1210/jcem-54-3-608
  34. Vittek, J., Munnangi, P.R., Gordon, G.G., Rappaport, S. and Southren, A.L.: Progesterone receptors in human gingiva. IRCS Med. Sci. 10:381-384, 1982b
  35. Wong, B.R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F.S. 3rd., Frankel, W.N., Lee, S.Y. and Choi, Y.: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190-25194, 1997 https://doi.org/10.1074/jbc.272.40.25190
  36. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T.: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95:3597-3602, 1998